Publications

A list of Prof. Dr. Adelheid Cerwenka's publications can be also found on PubMed.

Most important publications

• Ferreira C, Barros L, Baptista M, Blankenhaus B, Barros A, Figueiredo-Campos P, Konjar Š, Lainé A, Kamenjarin N, Stojanovic A, Cerwenka A, Probst HC, Marie JC, Veldhoen M. Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells. Nat Immunol. 2020 Jul;21(7):766-776. doi: 10.1038/s41590-020-0674-9. Epub 2020 May 18.
• Ni J, Wang X, Stojanovic A, Zhang Q, Wincher M, Bühler L, Arnold A, Correia MP, Winkler M, Koch PS, Sexl V, Höfer T, Cerwenka A. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity. Immunity. 2020 Jun 16;52(6):1075-1087.e8. doi: 10.1016/j.immuni.2020.05.001. Epub 2020 May 22.PMID: 32445619
• Stojanovic A, Cerwenka A. Checkpoint inhibition: NK cells enter the scene. Nat Immunol. 2018 Jul;19(7):650-652. doi: 10.1038/s41590-018-0142-y. No abstract available.
• Correia MP, Stojanovic A, Bauer K, Juraeva D, Tykocinski LO, Lorenz HM, Brors B, Cerwenka A. Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential. Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5980-E5989. doi: 10.1073/pnas.1720564115. Epub 2018 Jun 12
• Pahl JHW, Koch J, Götz JJ, Arnold A, Reusch U, Gantke T, Rajkovic E, Treder MS, Cerwenka A. CD16A activation of NK cells promotes NK cell proliferation and memory-like cytotoxicity against cancer cells. Cancer Immunol Res. 2018 May;6(5):517-527. doi: 10.1158/2326-6066.CIR-17-0550. Epub 2018 Mar 7.
• Cerwenka A, Lanier LL. Natural killers join the fight against cancer. Science. 2018 Mar 30;359(6383):1460-1461. doi: 10.1126/science.aat2184. No abstract available.
• Pollmann J, Götz JJ, Rupp D, Strauss O, Granzin M, Grünvogel O, Mutz P, Kramer C, Lasitschka F, Lohmann V, Björkström NK, Thimme R, Bartenschlager R, Cerwenka A. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. J Hepatol. 2018 Mar;68(3):421-430. doi: 10.1016/j.jhep.2017.10.021. Epub 2017 Nov 1.
• Cerwenka A, Lanier LL. NK cell memory in viral infection, inflammation and cancer. Nature Immunology Reviews 2016 Feb;16(2):112-23. doi: 10.1038/nri.2015.9.
• Rölle A, Pollmann J, Ewen E, Halenius A, Hengel H, Cerwenka A. IL-12 producing monocytes and HLA-E drive NKG2C+ NK cell expansion in HCMV infection. J. Clin. Invest. 2014, Nov 10. pii: 77440. doi: 10.1172/JCI77440.
• Stojanovic A, Fiegler N, Brunner-Weinzierl M and Cerwenka A. CTLA-4 is expressed by activated mouse NK cells and inhibits NK cell IFN-g production in response to mature dendritic cells. J Immunol. 2014 May 1;192(9):4184-91.
• Fiegler N, et al.  Cerwenka A. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells. Blood  2013, 122(5):684-693.
• Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18 preactivated NK cells against established tumors. J Exp Med. 2012, 209(13):2351-2365.
• Cerwenka A, Bakker ABH,  McClanahan T, Wagner J, Wu J, Phillips JH and Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000, 12: 721-727.